S1 Guideline: Impairment of gonadal function After Cancer in Childhood and Adolescence.
Anja Borgmann-StaudtAndreas JantkeStefan HinzMatthias BeckmannRalf DittrichLaura LotzMagdalena BalcerekPublished in: Klinische Padiatrie (2023)
A possible negative consequence of cancer treatment is the fertility impairment of young cancer survivors. However, most former patients express the wish to have biological children. Fertility-preserving measures are available and are - under certain circumstances - financed by health insurance. Separate information at the time of diagnosis and during follow-up care should be adapted to the individual risk and enable those affected to make a self-determined decision about cryopreservation of germ cells or germ cell tissue. Hyopgonadotropic hypogonadism can be treated by the pulsatile administration of gonadotropins. Affected individuals can be reassured. A health restriction of the offspring due to the cancer treatment is not to be expected, even after artificial insemination.
Keyphrases
- health insurance
- childhood cancer
- young adults
- healthcare
- affordable care act
- germ cell
- newly diagnosed
- end stage renal disease
- ejection fraction
- induced apoptosis
- public health
- palliative care
- depressive symptoms
- high fat diet
- prognostic factors
- peritoneal dialysis
- cell cycle arrest
- risk assessment
- skeletal muscle
- type diabetes
- signaling pathway
- adipose tissue
- middle aged
- cell death
- squamous cell
- climate change
- insulin resistance
- human health